TrialTrials2016

Evaluation of the vascular protective effects of new oral anticoagulants in high-risk patients with atrial fibrillation (PREFER-AF): study protocol for a randomized controlled trial.

Jin-Bae Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.